Menu
GeneBe

19-14587676-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001204118.2(CLEC17A):​c.184C>T​(p.Leu62Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000293 in 1,606,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L62I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000020 ( 0 hom. )

Consequence

CLEC17A
NM_001204118.2 missense

Scores

1
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.29
Variant links:
Genes affected
CLEC17A (HGNC:34520): (C-type lectin domain containing 17A) Enables fucose binding activity; identical protein binding activity; and mannose binding activity. Located in cell surface. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.16183534).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CLEC17ANM_001204118.2 linkuse as main transcriptc.184C>T p.Leu62Phe missense_variant 3/14 ENST00000417570.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CLEC17AENST00000417570.6 linkuse as main transcriptc.184C>T p.Leu62Phe missense_variant 3/141 NM_001204118.2 P1Q6ZS10-1
CLEC17AENST00000339847.9 linkuse as main transcriptc.184C>T p.Leu62Phe missense_variant, NMD_transcript_variant 3/131 Q6ZS10-2
CLEC17AENST00000551730.1 linkuse as main transcriptc.184C>T p.Leu62Phe missense_variant, NMD_transcript_variant 3/141
CLEC17AENST00000547437.5 linkuse as main transcriptc.184C>T p.Leu62Phe missense_variant 3/132 Q6ZS10-3

Frequencies

GnomAD3 genomes
AF:
0.000118
AC:
18
AN:
152088
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000435
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000258
AC:
6
AN:
232924
Hom.:
0
AF XY:
0.0000159
AC XY:
2
AN XY:
126064
show subpopulations
Gnomad AFR exome
AF:
0.000281
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000191
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000199
AC:
29
AN:
1453994
Hom.:
0
Cov.:
32
AF XY:
0.0000180
AC XY:
13
AN XY:
722574
show subpopulations
Gnomad4 AFR exome
AF:
0.000300
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000171
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.000118
AC:
18
AN:
152088
Hom.:
0
Cov.:
31
AF XY:
0.000108
AC XY:
8
AN XY:
74302
show subpopulations
Gnomad4 AFR
AF:
0.000435
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000113
ESP6500AA
AF:
0.000541
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000331
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 20, 2021The c.184C>T (p.L62F) alteration is located in exon 3 (coding exon 3) of the CLEC17A gene. This alteration results from a C to T substitution at nucleotide position 184, causing the leucine (L) at amino acid position 62 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.37
CADD
Pathogenic
26
DANN
Uncertain
1.0
Eigen
Uncertain
0.28
Eigen_PC
Benign
0.17
FATHMM_MKL
Benign
0.62
D
LIST_S2
Benign
0.52
T;T
M_CAP
Benign
0.0084
T
MetaRNN
Benign
0.16
T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
1.7
L;L
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.37
N;N
REVEL
Benign
0.056
Sift
Pathogenic
0.0
D;T
Sift4G
Benign
0.076
T;T
Polyphen
1.0
D;D
Vest4
0.34
MVP
0.81
MPC
3.2
ClinPred
0.61
D
GERP RS
2.3
Varity_R
0.097
gMVP
0.016

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs371803480; hg19: chr19-14698488; API